15 Jun 09

Unless it paints the right picture you’re letting the side down!

In a depressed job market, an employer is likely to receive 50+ CVs per job advertised from 5 or more Preferred Agencies and many more from agencies who ‘piggy back’ in. So now, more than ever, your CV needs to stand out and be tailored to the role and client and submitted by an agency with valid access.
Avril Horn PhD

12 Jun 09

Datamonitor attended the American Society of Clinical Oncology's 45th Annual Meeting in Orlando, Florida, to assess the key highlights of the conference. A number of promising presentations evaluated the potential of currently marketed agents to successfully combine with conventional chemotherapy in indications with persistent high unmet needs.
Datamonitor

11 Jun 09

Dr Wolfgang Wein, Executive Vice-President of Merck Serono’s Oncology Business comments on the recent final appraisal determination by NICE paving the way for its leading oncology product Erbitux to benefit UK mCRC patients.
Olwen Glynn Owen - Pharmiweb Field reporter

05 Jun 09

Despite the pharmaceutical industry's evolving business model in response to growing regulatory constraints, the sector is facing unprecedented challenges caused by the economic downturn and President Obama's planned overhaul of the US healthcare system. To continue on its journey towards 'Pharma 2.0', the industry must balance the more pressing short term issues against longer term trends
Priyanka Adhikari - Datamonitor

01 Jun 09

The Department of Health is determined to improve commissioning, and it will do whatever it takes to make it happen. That is the message that senior departmental officials sent to practice based commissioners last week at a National Association of Primary Care conference in London.
Miriam George

01 Jun 09

The time has arrived for primary care trusts to shed their provider functions, and it is causing considerable angst in the community services sector. It was inevitable that sooner or later, the split would have to happen, but now the race is on to decide what organisation model they want to adopt: foundation trust or social enterprise?
Miriam George

11 May 09

The recent outbreak of influenza A (H1N1) infection, previously referred to as swine flu, has thrown the spotlight on governments around the world and their ability to manage a pandemic. In the UAE, customers are currently finding it difficult to source antivirals but, with Dubai seen as a hub for international travel, the government has stockpiles ready for distribution should an outbreak occur.
Datamonitor

06 May 09

The inspiration for this article came to me when watching an interview with Mr N R Narayanmurthy, Chief Mentor at Infosys. I was particularly taken by his control and poise; clearly, someone with years of training and experience in being interviewed can be completely at ease in such a stressful situation, but it made me think about how we can all improve our own techniques and create that vital positive first impression.
Shanoo Singh

05 May 09

As part of the UK government's drive to save over GBP2 billion in the NHS during 2010-11, GBP550m will be cut from the prices of branded drugs as a result of the revised Pharmaceutical Price Regulation Scheme. With the volume of branded drugs having remained flat over the last four years, total sales of the UK branded pharmaceutical industry are forecast to decline from 2009 onwards.
Editor

30 Apr 09

The latest outbreak of influenza virus H1N1 “swine flu” is now widely tipped to cause a global pandemic of unknown severity. Previously, the influenza vaccine community discussed the theoretical limitations of current technologies and capacity. Now they are faced with the reality of these limitations. VacZine Analytics believes H1N1 must change the science of influenza vaccines.
VacZine Analytics Group

30 Apr 09

Where the pharmaceutical industry is often said to be immune to economic depression, the current economic crisis cannot be considered a direct historical equal to the recessions of the past.
Max Golby

28 Apr 09

Public opinion has for long been regarded as essential to the success of a thriving business. In fact, whilst the benefits of popular perception can often appear somewhat intangible on the balance sheet, what is essentially the respect of the customer is the bastion of almost every profession
Max Golby

20 Apr 09

Despite the current economic downturn, pharmaceutical research & development spending continues to play a vital role in the pharmaceutical industry. The industry, as a whole, needs to find new, more innovative ways to compensate for the recent and upcoming patent loses of many blockbusters products...
CBR Pharma Insights

11 Mar 09

In January, leading pharmaceutical experts attended the 2009 Forum Institute seminar on biosimilars, and the challenges involved in their successful development and launch. While the main focus of the meeting the biosimilars market in the EU, it was widely agreed that developments in the US, and President Obama's handling of the generic biotech issue, will be the defining issue of 2009 and beyond.
Editor

10 Mar 09

Job satisfaction is an attitude that employees have about their work and is based on numerous factors, both intrinsic and extrinsic to the individual. Job satisfaction is important from the perspective of maintaining and retaining the appropriate employees within the organization; it is about fitting the right person to the right job in the right culture and keeping them satisfied.1,2
Toni Lakin - Phlexglobal Ltd

09 Mar 09

Drug Repositioning Strategies is a report that provides in-depth analysis of leading pharma companies that are using novel technologies to reposition failed, marketed or reformulated compounds.
Editor

09 Mar 09

Matt Greig at Advanced Regulatory provides an overview on *** Option Suisse *** and gives an introduction to working and living in Switzerland.
Matt Greig - Advanced Regulatory

05 Mar 09

A recent market analysis survey* into the employment trends and aspirations of clinical research professionals working in the Clinical Research sectors has confirmed the move and willingness of people to consider independent contract based employment.
Rachel Corbishley - Redtree

23 Feb 09

Health economics is a growing sub-discipline of economics and studies the allocation of scarce resources in health care.
Editor

20 Feb 09

More than a billion people worldwide are affected by the consequences of high blood pressure and many more suffer without diagnosis, due to a lack of ubiquitous symptoms...
Max Golby

29 Jan 09

Recent talks are about the recession, economic downturn, credit crunch and so on. However, the pharma giant Pfizer made a remarkable start in 2009.
A. Shabeer Hussain

28 Jan 09

We're living longer, but many challenges remain The third national Health Profile of England is published today and demonstrates improvements in critical areas of the nation's health.
Editor

07 Jan 09

PharmiWeb is pleased to collaborate with Touch Briefings to provide clinical research professionals FREE access to their latest report - Clinical Trial Management: Enabling Operational Efficiency.
Liam ONeill

06 Jan 09

The Nanotechnology Knowledge Transfer Network (NanoKTN), one of the UK’s primary knowledge-based networks for Micro and Nanotechnologies, has announced its support for one of the largest funding rounds that has been made available to the micro and nanotechnology sector.
Graham Thatcher

02 Jan 09

One person is diagnosed with diabetes every three minutes* in the UK, according to new figures from Diabetes UK.
Fabienne Jacquet

18 Dec 08

According to Diabetes UK, over 2.5 Million people in the UK suffer from diabetes, with half a million of them being unaware they have it.

There are 2 forms of diabetes, and the causes of both types are different, but both result in too much glucose (sugar) in the blood.
Editor

18 Dec 08

A £12 million action plan to improve services for children and young people with speech, language and communication needs was launched today by Health Secretary Alan Johnson and Children's Secretary Ed Balls.
Editor

16 Dec 08

Naseem Javed, widely recognized as global authority on global corporate nomenclature, image and cyber-branding, author of Naming for Power. Naseem is on global name identity projects and lecturing at various conferences on these ICANN issues.
Naseem Javed

05 Dec 08

Patients are being urged to put people power into action from today by rating the service they receive in hospitals using a new tool on the NHS website.
Editor

03 Dec 08

Paul Hartigan reports from the Financial Times Pharmaceutical Conference: London December 2nd and 3rd 2008
Paul Hartigan